MedPath

Intervention for Employed Women With Multiple Sclerosis

Not Applicable
Conditions
Multiple Sclerosis
Registration Number
NCT04100525
Lead Sponsor
Holy Name Medical Center, Inc.
Brief Summary

Unemployment is particularly common among women with multiple sclerosis (MS). This study uses a vocational rehabilitation program involving neuropsychological testing as an intervention. The use of in-person feedback and case management following neuropsychological testing is compared to phone feedback only. Adherence to treatment and employment outcomes will be evaluated over three years.

Detailed Description

Employed women at a tertiary-care MS center were screened for common issues impacting work productivity (fatigue, cognitive dysfunction, and depression). Women who met screening criteria were randomized to one of two treatment groups: either neuropsychological testing and phone feedback to review findings and tailored recommendations (standard-care treatment); or neuropsychological testing, in-person feedback, and two calls from a care-coordinator (experimental treatment). Adherence to recommendations and employment status at one year are evaluated. Follow-up periods also occur at year two and year three.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
89
Inclusion Criteria
  • Female sex
  • Age between 18 and 64
  • Employed at least 20 hours per week
  • Confirmed diagnosis of MS
Exclusion Criteria
  • Experiencing an MS exacerbation
  • Endorsing suicidal ideation or intent
  • Pregnant
  • Severe psychiatric disorder
  • History of traumatic brain injury
  • Dementia
  • Major neurological illness other than MS

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
EmploymentApproximately 12 months

Has there been a decrease in employment status (Yes/No)

Secondary Outcome Measures
NameTimeMethod
Adherence to RecommendationsApproximately 12 months

Percentage of recommendations completed at one year

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.